publication venue for
- Cholangiocarcinoma: bridging the translational gap from preclinical to clinical development and implications for future therapy.. 30:365-375. 2021
- Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders.. 30:1-4. 2021
- Use of a bioengineered antioxidant in mouse models of metabolic syndrome.. 29:209-219. 2020
- Investigational approaches to therapies for idiopathic pulmonary fibrosis.. 19:737-745. 2010
- Novel agents in the therapy of endotoxic shock.. 9:1363-1372. 2000
- Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer.. 8:1385-1396. 1999